Prevalence and Impact of Dementia-related Functional Limitations in the United States, 2001 to 2005

被引:15
作者
Arrighi, Henry Michael [1 ]
McLaughlin, Trent [1 ]
Leibman, Christopher [1 ]
机构
[1] Elan Pharmaceut Inc, San Francisco, CA 94080 USA
关键词
Alzheimer disease; dementia; comorbidity; ALZHEIMER-DISEASE; COSTS; COMORBIDITIES; IMPAIRMENT; MEDICARE; BURDEN;
D O I
10.1097/WAD.0b013e3181a1a87d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
These analyses examined the relationship between dementia and comorbid conditions with respect to degree of functional impairment and emotional impact. Analyses were conducted using National Health Interview Survey (2001 through 2005) data from a subset of individuals aged >= 60 years with activity limitations attributed to dementia, senility, or Alzheimer disease compared with those whose limitations were attributed to other conditions. The mean number of limited activities was 6.84 (95% confidence interval: 6.48-7.20) for persons with dementia-related limitations and 4.87 (95% confidence interval: 4.81-4.93) for those with limitations not dementia related. Both groups reported similar prevalence of diabetes, acute myocardial infarction, heart disease, prostate cancer, breast cancer, angina, and emphysema; respondents with dementia-related functional limitations were more likely to report diabetes, depression or anxiety, and vision problems as being related to functional limitations. Persons with dementia-related functional limitations were also more likely than persons with non-dementia-related functional limitations to report feeling sad, hopeless, worthless, nervous, and that "everything is an effort." Improving or maintaining functional independence in patients with dementia will likely require a multifaceted approach across disease states. Additional research will help define the impact of dementia on the development and progression of functional limitations related to comorbidities.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 22 条
[1]  
*ALZH ASS, 2007, ALZH DIS FACTS FIG 2, P5
[2]  
[Anonymous], 2002, DAT FIL DOC NAT HLTH
[3]   Forecasting the global burden of Alzheimer's disease [J].
Brookmeyer, Ron ;
Johnson, Elizabeth ;
Ziegler-Graham, Kathryn ;
Arrighi, H. Michael .
ALZHEIMERS & DEMENTIA, 2007, 3 (03) :186-191
[4]   The temporal relationship between depressive symptoms and dementia -: A community-based prospective study [J].
Chen, PJ ;
Ganguli, M ;
Mulsant, BH ;
DeKosky, ST .
ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (03) :261-266
[5]   Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias [J].
Hill, J ;
Fillit, H ;
Thomas, SK ;
Chang, SB .
PHARMACOECONOMICS, 2006, 24 (03) :265-280
[6]   Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare [J].
Hill, JW ;
Futterman, R ;
Duttagupta, S ;
Mastey, V ;
Lloyd, JR ;
Fillit, I .
NEUROLOGY, 2002, 58 (01) :62-70
[7]   Medicare expenditures associated with Alzheimer disease [J].
Kane, RL ;
Atherly, A .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 (04) :187-195
[8]   SENILE DEMENTIA OF THE ALZHEIMER TYPE - AN IMPORTANT RISK FACTOR FOR SERIOUS FALLS [J].
MORRIS, JC ;
RUBIN, EH ;
MORRIS, EJ ;
MANDEL, SA .
JOURNALS OF GERONTOLOGY, 1987, 42 (04) :412-417
[9]  
*NAT CTR HLTH STAT, 2005 NAT HLTH INT SU
[10]  
*NAT CTR HLTH STAT, 2004 NAT HLTH INT SU